For following the competition: what moved in each program, several studies read as one move.
- ULSC
- FT839
- Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes
- + 13 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Dermatomyositis to watchlistEvery Monday by email · turn it off any timePro · free during the beta